Atopic Dermatitis (Atopic Eczema) - Global Clinical Trials Review, 2026

Description

List of Tables

GlobalData's clinical trial report, "Atopic Dermatitis (Atopic Eczema) - Global Clinical Trials Review, 2026" provides an overview of Atopic Dermatitis (Atopic Eczema) Clinical trials scenario. This report provides top line data relating to the clinical trials on Atopic Dermatitis (Atopic Eczema). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape
Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
The Report provides enrollment trends for the past five years
Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

Assists in formulating key business strategies with regards to investment
Helps in identifying prominent locations for conducting clinical trials which saves time and cost
Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
Supports understanding of trials count and enrollment trends by country in global therapeutics market
Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Product Code: GDHC7367CTIDB

List of Tables

List of Figures

Report Guidance
GlobalData Clinical Trials Report Coverage
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Atopic Dermatitis (Atopic Eczema) to Dermatology Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Atopic Dermatitis (Atopic Eczema) to Dermatology Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on Atopic Dermatitis (Atopic Eczema)
Aug 26, 2026: TRexBio Announces Positive Topline Results From First-In-Human Phase 1A Study of TRB-061, a TNFR2 Agonist in Clinical Development for AD
Aug 25, 2026: Nektar Announces Publication in The Lancet of Positive Phase 2b REZOLVE-AD 16-Week Induction Results of Rezpegaldesleukin in AD
Aug 24, 2026: April Bio Signs APB-R3 Material Transfer Agreement with Evomune, Preparing for Follow-up Development
Aug 13, 2026: Photys Therapeutics and Polymed Biopharmaceuticals Announce the Initiation of a Phase I Clinical Trial of PHT-776/HPB-143
Aug 13, 2026: The Innovative Drug HSK60002 Tablets Has Received Clinical Trial Approval for the Treatment of Inflammatory Diseases
Aug 04, 2026: Nurix Announces $10 Million Milestone Payment Associated With Initiation of a Phase 1 Clinical Trial of a STAT6 Degrader
Jul 27, 2026: Organon reports new findings from Vtama atopic dermatitis trials
Jul 27, 2026: Bambusa Reports Potentially Transformative Preliminary Results for BBT001 in Atopic Dermatitis, Reinforcing Its Best-in-Disease Potential
Jul 24, 2026: Sanofi abandons eczema drug approval efforts in another blow to OX40 class
Jul 23, 2026: Enveda's Phase 1B Results for ENV-294, Oral Therapy for AD, Presented at AAD Innovation Academy; Additional Details to Be Shared at EADV
Jul 21, 2026: Nektar Announces Start of Phase 3 ZENITH AD Program Evaluating Novel Regulatory T-Cell Biologic Rezpegaldesleukin in Atopic Dermatitis
Jul 21, 2026: Pharmability approved by the Swedish Medical Products Agency to start Phase Ib trial of TIR-C in atopic dermatitis
Jul 20, 2026: LAPIX Therapeutics Announces Completion of Enrollment in Rheumatoid Arthritis Arm of Ongoing LPX-TI641 Clinical Study
Jul 16, 2026: Harbour BioMed and Kelun-Biotech receive China IND approval for asthma therapy
Jul 15, 2026: InnoCare Announces Phase III Study Results of TYK2 Inhibitor Soficitinib Meet Primary Endpoint in Patients with Atomic Dermatitis
Jul 13, 2026: STAT6 Degrader BCR-0008 Accepted by NMPA -- Achievements of Baixin Bio's PROTAC Technology Platform
Jul 09, 2026: LEO Pharma Announces Results of Phase 2 TRAPEDS-1 Trial Evaluating Pharmacokinetics and Safety of Tralokinumab in Children With Atopic Dermatitis
Jul 08, 2026: Turn Therapeutics' stock jumps on AD data and trial expansion
Jul 07, 2026: Organon to Present New Analysis on VTAMA (tapinarof) cream, 1%, at the 2026 Society for Pediatric Dermatology Annual Meeting
Jul 06, 2026: Turn Therapeutics to Host Webcast Presenting Comprehensive Interim Analysis and Optimized Stage 2 Design for GX-03 in Atopic Dermatitis
Jun 25, 2026: Kymera Completes Enrollment in the Phase 2b BROADEN2 Trial of KT-621 in Atopic Dermatitis with Topline Data by Year-end 2026
Jun 25, 2026: Leo Pharma to Showcase New Data Highlighting the Burden and Unmet Needs in Chronic Hand Eczema at ESCD 2026 in Copenhagen
Jun 22, 2026: New Long-Term Data Shows Lebrikizumab Sustains Atopic Dermatitis Clearance With Less Frequent Dosing and Advances Findings
Jun 12, 2026: Kymera Therapeutics Presents Phase 1 Data in Healthy Japanese Adults for KT-621, a First-In-Class Oral STAT6 Degrader, at the JDA Annual Meeting
Jun 12, 2026: Recludix Pharma To Present Preclinical Asthma and Dermatitis Data for Oral STAT6 Inhibitor REX-8756 at the EAACI and RAD Congresses
Jun 05, 2026: Pharmability Submits Clinical Trial Application for First-In-Human Phase Ib Study of TIR-C in Atopic Dermatitis
Jun 01, 2026: Turn Reports Interim Analysis Findings and Adaptive Optimization Strategy from Phase 2 GX-03 Trial in Moderate-to-Severe Atopic Dermatitis
Clinical Trial Profile Snapshots

Appendix

Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Source

Product Code: GDHC7367CTIDB

List of Table

List of Tables

Atopic Dermatitis (Atopic Eczema) Therapeutics, Global, Clinical Trials by Region, 2026*
Atopic Dermatitis (Atopic Eczema) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2026*
Atopic Dermatitis (Atopic Eczema) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2026*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2026*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Europe, Top Five Countries, 2026*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, North America, Top Countries, 2026*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2026*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2026*
Proportion of Atopic Dermatitis (Atopic Eczema) to Dermatology Clinical Trials, G7 Countries (%), 2026*
Atopic Dermatitis (Atopic Eczema) Therapeutics, G7 Countries, Clinical Trials by Phase, 2026*
Atopic Dermatitis (Atopic Eczema) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2026*
Proportion of Atopic Dermatitis (Atopic Eczema) to Dermatology Clinical Trials, E7 Countries (%), 2026*
Atopic Dermatitis (Atopic Eczema) Therapeutics, E7 Countries, Clinical Trials by Phase, 2026*
Atopic Dermatitis (Atopic Eczema) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2026*
Atopic Dermatitis (Atopic Eczema) Therapeutics, Global, Clinical Trials by Phase, 2026*
Atopic Dermatitis (Atopic Eczema) Therapeutics, Global, Clinical Trials In Progress by Phase 2026*
Atopic Dermatitis (Atopic Eczema) Therapeutics, Global, Clinical Trials by Trial Status, 2026*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Global, by End Point Status, 2026*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2021-2025
Atopic Dermatitis (Atopic Eczema) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2026*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Global, Key Sponsors, 2026*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2026*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2026*

List of Figure

List of Figures

Atopic Dermatitis (Atopic Eczema) Therapeutics, Global, Clinical Trials by Region (%), 2026*
Atopic Dermatitis (Atopic Eczema) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2026*
Atopic Dermatitis (Atopic Eczema) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2026*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2026*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2026*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, North America, Top Countries (%), 2026*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2026*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2026*
Proportion of Atopic Dermatitis (Atopic Eczema) to Dermatology Clinical Trials, G7 Countries (%), 2026*
Atopic Dermatitis (Atopic Eczema) Therapeutics, G7 Countries, Clinical Trials by Phase, 2026*
Atopic Dermatitis (Atopic Eczema) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2026*
Proportion of Atopic Dermatitis (Atopic Eczema) to Dermatology Clinical Trials, E7 Countries (%), 2026*
Atopic Dermatitis (Atopic Eczema) Therapeutics, E7 Countries, Clinical Trials by Phase, 2026*
Atopic Dermatitis (Atopic Eczema) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2026*
Atopic Dermatitis (Atopic Eczema) Therapeutics, Global, Clinical Trials by Phase (%), 2026*
Atopic Dermatitis (Atopic Eczema) Therapeutics, Global, Clinical Trials In Progress by Phase, 2026*
Atopic Dermatitis (Atopic Eczema) Therapeutics, Global, Clinical Trials by Trial Status, 2026*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Global, by End Point Status, 2026*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2021-2025
Atopic Dermatitis (Atopic Eczema) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2026*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Global, Key Sponsors, 2026*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2026*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2026*
GlobalData Methodology

Atopic Dermatitis (Atopic Eczema) - Global Clinical Trials Review, 2026

Description

Table of Contents

List of Tables

Scope

Reasons to Buy

Table of Contents

Table of Contents

List of Tables

List of Figures

Appendix

List of Table

List of Tables

List of Figure

List of Figures